Riskpilot← Back to searchSign inGet full accessOPTIKK NØKLEHOLM AS
ASActiveOrg 982609674Storgata 11, 2335 StangeRetail sale of medical and orthopaedic goods · NACE 4774Est. 20000 employees
Revenue 2025
NOK 213K
0% vs 2024
EBITDA margin
-0.7%
-102% vs 2024
Equity ratio
81.0%
Financial strength
Net profit 2025
NOK 2,4M
+3% vs 2024
| Revenue | NOK 213K | +0% |
| EBITDA | NOK -1K | -102% |
| Net profit | NOK 2,4M | +3% |
| Total assets | NOK 11,4M | +19% |
| Equity | NOK 9,2M | +11% |
| Employees | 0 | — |
Legal name
OPTIKK NØKLEHOLM AS
Org number
982609674
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
22. november 2000
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Kjøp og salg av optiske tjenester, annen virksomhet som naturlig hører inn under dette, og ved aksjeeie eller på annen måte delta i andre foretak med beslektet virksomhet.
Address
Storgata 11, 2335 Stange
Phone
+4762571129
Email
stange@no.specsavers.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 420 | 8 101 | 2 616 | 213 | 213 |
| Staff expenses | −1 901 | −1 828 | 4 | −0 | −0 |
| EBITDA | 1 209 | 1 823 | 2 340 | 73 | −1 |
| Depreciation & amort. | −253 | −310 | −81 | −4 | −0 |
| EBIT | 956 | 1 513 | 2 259 | 69 | −1 |
| Net financials | 1 386 | 707 | 1 426 | 2 309 | 2 563 |
| Profit before tax | 2 342 | 2 220 | 3 685 | 2 378 | 2 561 |
| Tax | 223 | 358 | 132 | 161 | 138 |
| Net profit | 2 137 | 1 900 | 3 051 | 2 303 | 2 380 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 492 | 6 324 | 7 938 | 9 601 | 11 377 |
| Equity | 2 586 | 3 986 | 6 537 | 8 340 | 9 220 |
| Long-term debt | 733 | 493 | 556 | 469 | 513 |
| Short-term debt | 2 173 | 1 845 | 845 | 791 | 1 644 |
| Total debt | 2 906 | 2 338 | 1 401 | 1 260 | 2 157 |
EBITDA margin
-0.7%
This company
15.8%
Market median
-104% vs market
20212025
Equity ratio
81.0%
This company
38.2%
Market median
+112% vs market
20212025
Return on equity
25.8%
This company
18.4%
Market median
+40% vs market
20212025
Net profit margin
1119.7%
This company
8.1%
Market median
+13723% vs market
20212025
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20212025
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HN Chief Executive Officer | Chief Executive Officer | 2000 |
ML Deputy Member | Deputy Member | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OPTIKK NØKLEHOLM AS 
OPTIKK ELVERUM ASBoard members of OPTIKK NØKLEHOLM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Harald Nøkleholm | Chief Executive Officer | 0 companies |
| Magnus Larsson Rodvang | Deputy Member | 0 companies |
| Erik Rodvang | Chairman | 0 companies |